A new clinical trial published in the journal BMC Complementary and Alternative Medicine is shedding light on turmeric's remarkable liver protective and regenerative properties. South Korean researchers at the Clinical Trial Center for Functional Foods, Chonbuk National University Hospital, tested their hypothesis that turmeric may improve liver function by administering a fermented form to subjects, 20 years old and above, who were diagnosed mild to moderate elevated alanine aminotransferase (ALT) levels, a maker for liver damage and/or dysfunction.
Sixty subjects were randomized to receive 3.0 g per fermented turmeric powder (FTP) or placebo 3.0 g per day for 12 weeks. The treatment group received two capsules of FTP three times a day after meals, for 12 weeks. Not only did FTP significantly reduce ALT levels in subjects but also reduced serum aspartate transaminase (AST) and gamma-glutamyltransferase (GGT), two additional enzymes which when elevated are commonly associated with liver damage. The effects were maintained as long as the subjects remained on the treatment. Also, FTP was well tolerated and without significant adverse effects...read more>>>...
